Financial details of the deal were not disclosed
Dako Agilent Technologies and Cell Signaling Technology (CST) has announced that they have entered into a strategic partnership to supply antibodies for use in Dako-branded companion diagnostics products.
Agilent Diagnostics and genomics president Mr Jacob Thaysen said, "We are pleased that collaboration with the CST, and development partner of high quality, advanced diagnostic reagents products, these products will be an important tool for cancer diagnosis and treatment."
CST's chief executive, Mr Michael J Comb said, "CST recognizes that improving our methods of diagnosis and treatment of cancer patients, and companion diagnostic reagents products have great potential. We are confident that this partnership will allow our products to contribute to advances in personalized medicine."
Financial details of the deal were not disclosed.